⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INO News
Inovio Pharmaceuticals, Inc.
Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence Now Available. Tracks 960+ Organizations and 2,100+ Drugs Across the Full Cancer Vaccine Pipeline
globenewswire.com
INO
BNTX
GSK
INOVIO to Participate in Upcoming Investor Conferences
prnewswire.com
INO
Form 8-K
sec.gov
INO
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
prnewswire.com
INO
Form 8-K
sec.gov
INO
INOVIO Announces Pricing of $20.0 Million Public Offering
prnewswire.com
INO
Form 8-K
sec.gov
INO
INOVIO Announces Proposed Public Offering
prnewswire.com
INO
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
prnewswire.com
INO